Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical

Gardasil Review: Will HPV Vaccine Be Inoculated Against Plan B Politics?

  • News

Executive Summary

HHS regulatory decisions on human papilloma virus vaccines will likely face heightened scrutiny following revelations about FDA's decision-making process on the Rx-to-OTC switch application for Plan B

You may also be interested in...



HPV Vaccines Receive Narrow Age-Range Endorsement From ACIP Workgroup

A workgroup of CDC's Advisory Committee on Immunization Practices is recommending routine vaccination with quadrivalent human papillomavirus vaccine for females ages 11 to 12

HPV Vaccines Receive Narrow Age-Range Endorsement From ACIP Workgroup

A workgroup of CDC's Advisory Committee on Immunization Practices is recommending routine vaccination with quadrivalent human papillomavirus vaccine for females ages 11 to 12

Gardasil Goes To FDA; Merck Hopes For Mid-Year Approval Of HPV Vaccine

Merck could have a strong case for priority review of its human papillomavirus vaccine Gardasil

Table

View full table

Related Content

Pink Sheet
Pink Sheet

Topics

Tags:
BioPharmaceutical
UsernamePublicRestriction

Register

LL1131980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By